CLSD

Dopo l'orario di chiusura: 1.28 0.01 +0.79%

Clearside Biomedical Inc (CLSD)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Clearside Biomedical Inc Stock (CLSD) Company Profile

Clearside Biomedical Inc

678-270-3631

900 NORTH POINT PARKWAY, ALPHARETTA, GA

Prossima data di guadagno

Ultimi documenti SEC

CLSD's Discussions on Twitter

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-12-15	Ripresa	Wedbush	Outperform
2021-07-29	Iniziato	H.C. Wainwright	Buy
2020-05-13	Iniziato	ROTH Capital	Buy
2019-08-09	Downgrade	Needham	Buy → Hold
2018-11-05	Downgrade	Cowen	Outperform → Market Perform
2018-11-05	Downgrade	JP Morgan	Overweight → Underweight
2018-11-05	Downgrade	Stifel	Buy → Hold
2018-03-06	Reiterato	Needham	Buy
2017-05-25	Iniziato	JMP Securities	Mkt Outperform
2017-02-24	Iniziato	JP Morgan	Overweight
2016-11-10	Reiterato	Needham	Buy
2016-10-24	Reiterato	Stifel	Buy

Mostra tutto

Clearside Biomedical Inc Borsa (CLSD) Ultime notizie

Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari

Clearside Biomedical Inc (CLSD)

Clearside Biomedical Inc Stock (CLSD) Company Profile

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

Clearside Biomedical Inc Borsa (CLSD) Ultime notizie

Wall Street SWOT: Clearside Biomedical stock eyes ODYSSEY trial success - Investing.com

Armistice Capital LLC Has $2.78 Million Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat

CLSD’s Stock Market Journey: A Year of Growth, Decline, and Uncertainty - The InvestChronicle

Financial Health Report: Clearside Biomedical Inc (CLSD)’s Ratios Tell a Tale - The Dwinnex

Can Clearside's ODYSSEY Trial Data Delight Investors? - RTTNews

CLSD’s Stock Market Adventure: 5.13% YTD Growth Amidst Volatility - The InvestChronicle

Nothing is Better Than Clearside Biomedical Inc (CLSD) stock at the moment - SETE News

Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Increase in Short Interest - MarketBeat

Clearside Biomedical Inc [CLSD] Shares Rise 3.05 % on Thursday - Knox Daily

Was anything positive for Clearside Biomedical Inc (CLSD) stock last session? - US Post News

Clearside Biomedical Inc (CLSD) Stock: Navigating a Year of Volatility - The InvestChronicle

The Attractiveness of Investing In Clearside Biomedical Inc (CLSD) is Growing - Knox Daily

Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Rating of "Buy" from Brokerages - MarketBeat

International Assets Investment Management LLC Has $26,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World

Clearside Biomedical (NASDAQ:CLSD) Share Price Crosses Below Fifty Day Moving Average of $1.12 - MarketBeat

Market Resilience: Clearside Biomedical Inc (CLSD) Finishes Weak at 0.93, Down -3.40 - The Dwinnex

Analysts review Clearside Biomedical Inc’s rating - Knox Daily

Clearside Slips on Trials - MSN

Clearside Biomedical Inc [CLSD] Investment Guide: What You Need to Know - Knox Daily

Quarterly Metrics: Quick and Current Ratios for Clearside Biomedical Inc (CLSD) - The Dwinnex

Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - Defense World

Clearside Biomedical (NASDAQ:CLSD) Receives Buy Rating from HC Wainwright - MarketBeat

Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com Canada

Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com UK

Clearside Slips on Trials - Baystreet.ca

Clearside Biomedical Announces Completion of Final - GlobeNewswire

Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD - StockTitan

Assenagon Asset Management S.A. Buys Shares of 283,193 Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World

Brokers Issue Forecasts for Clearside Biomedical, Inc.'s FY2024 Earnings (NASDAQ:CLSD) - MarketBeat

Brokers Issue Forecasts for Clearside Biomedical, Inc.’s FY2024 Earnings (NASDAQ:CLSD) - Defense World

Assenagon Asset Management S.A. Takes $368,000 Position in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat

Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Analysts at Chardan Capital - MarketBeat

Clearside Biomedical (NASDAQ:CLSD) Research Coverage Started at Chardan Capital - Defense World

Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares Bought by Vanguard Group Inc. - Defense World

Clearside Biomedical (CLSD) Stock Price, News & Analysis - MarketBeat

Clearside Biomedical, Inc. (NASDAQ:CLSD) to Post Q3 2024 Earnings of ($0.13) Per Share, HC Wainwright Forecasts - Defense World

Q3 2024 EPS Estimates for Clearside Biomedical, Inc. (NASDAQ:CLSD) Increased by Analyst - MarketBeat

Oppenheimer gives an Outperform recommendation for Clearside Biomedical Inc (CLSD) - Knox Daily

Clearside Biomedical (NASDAQ:CLSD) Receives “Buy” Rating from HC Wainwright - Defense World

Clearside Biomedical (NASDAQ:CLSD) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Defense World

Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - Defense World

Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - MarketBeat

Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $4.60 Consensus Price Target from Analysts - MarketBeat

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Needham & Company LLC - MarketBeat

Clearside Biomedical (NASDAQ:CLSD) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at Needham & Company LLC - Defense World

CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online

Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CLSD